A Clinical Investigation of the Vanguard™ Complete Knee System

Last updated: September 4, 2024
Sponsor: Zimmer Biomet
Overall Status: Completed

Phase

N/A

Condition

Osteoarthritis

Rheumatoid Arthritis

Bone Diseases

Treatment

Vanguard™ Patient-Specific Femur

Vanguard™ Complete Knee System

Clinical Study ID

NCT00698854
ORTHO.CR.K005
  • Ages > 18
  • All Genders

Study Summary

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis,traumatic arthritis where one or more compartments are involved.

  • Correction of varus, valgus, or posttraumatic deformity

  • Correction or revision of unsuccessful osteotomy, or arthrodesis

Patient selection factors to be considered include:

  • Need to obtain pain relief and improve function

  • Ability and willingness of the patient to follow instructions

  • Including control of weight and activity level

  • Good nutritional state of the patient

  • Patient must have reached full skeletal maturity

Exclusion

Exclusion criteria:

Absolute contraindications include:

  • Infection

  • Sepsis

  • Osteomyelitis

  • Failure of a previous joint replacement

Relative contraindications include:

  • Uncooperative patient or patient with neurologic disorders who are incapable offollowing directions

  • Osteoporosis

  • Metabolic disorders which may impair bone formation

  • Osteomalacia

  • Distant foci of infections which may spread to the implant site

  • Rapid joint destruction, marked bone loss or bone resorption apparent onroentgenogram

  • Vascular insufficiency, Muscular atrophy, Neuromuscular disease

  • Incomplete or deficient soft tissue surrounding the knee

Additional exclusion criteria includes: failure of a previous joint replacement

Study Design

Total Participants: 552
Treatment Group(s): 2
Primary Treatment: Vanguard™ Patient-Specific Femur
Phase:
Study Start date:
March 01, 2004
Estimated Completion Date:
March 31, 2024

Study Description

This is a 10-year prospective observational data collection on the Vanguard Total Knee system. Patients are asked to come in for a preop, operative, immediate post-operative, 6 Month, 1 Year, 3 Year,5 Year, 7 year, and 10 year visits to check on the function, range of motion, and radiographic assessment of their total knee device.

The Vanguard Knee is an FDA cleared device, and has been on the market since 2004.

Connect with a study center

  • Physicians Clinic of Iowa Orthopedics

    Cedar Rapids, Iowa 52403
    United States

    Site Not Available

  • The Orthopaedic Center

    Rockville, Maryland 20850
    United States

    Site Not Available

  • Advanced Orthopedic Specialists

    Cape Girardeau, Missouri 63701
    United States

    Site Not Available

  • Orthopaedic Associates of Rochester

    Rochester, New York 14626
    United States

    Site Not Available

  • Texas Orthopedic Specialists

    Grapevine, Texas 76015
    United States

    Site Not Available

  • Orthopedic Associates

    Fishersville, Virginia 22939
    United States

    Site Not Available

  • Spokane Orthopedics

    Spokane, Washington 99207
    United States

    Site Not Available

  • Othopaedic & Sports Medicine Clinic of Monroe

    Monroe, Wisconsin 53566
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.